NO972558L - Sett for osteoporose-behandlingssyklus - Google Patents
Sett for osteoporose-behandlingssyklusInfo
- Publication number
- NO972558L NO972558L NO972558A NO972558A NO972558L NO 972558 L NO972558 L NO 972558L NO 972558 A NO972558 A NO 972558A NO 972558 A NO972558 A NO 972558A NO 972558 L NO972558 L NO 972558L
- Authority
- NO
- Norway
- Prior art keywords
- treatment cycle
- osteoporosis treatment
- osteoporosis
- solvate
- kit
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005324 tiludronic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9414630A FR2727629A1 (fr) | 1994-12-06 | 1994-12-06 | Trousse pour cycle de traitement de l'osteoporose |
| PCT/FR1995/001596 WO1996017616A1 (fr) | 1994-12-06 | 1995-12-05 | Trousse pour cycle de traitement de l'osteoporose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO972558D0 NO972558D0 (no) | 1997-06-05 |
| NO972558L true NO972558L (no) | 1997-08-05 |
Family
ID=9469504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO972558A NO972558L (no) | 1994-12-06 | 1997-06-05 | Sett for osteoporose-behandlingssyklus |
Country Status (20)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| MXPA04009586A (es) | 2002-05-10 | 2005-01-11 | Hoffmann La Roche | Acidos bisfosfonicos para el tratamiento y prevencion de la osteoporosis. |
| SI1790347T1 (sl) * | 2002-12-20 | 2015-03-31 | F. Hoffmann-La Roche Ag | Formulacija z visokim odmerkom ibandronata |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE66608T1 (de) * | 1984-04-30 | 1991-09-15 | Procter & Gamble | Ausruestung fuer die behandlung der osteoporose. |
| US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
| WO1994000129A1 (en) * | 1992-06-30 | 1994-01-06 | Procter & Gamble Pharmaceuticals, Inc. | Use of phosphonates for the treatment of osteoporosis |
| FR2694558B1 (fr) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
-
1994
- 1994-12-06 FR FR9414630A patent/FR2727629A1/fr active Granted
-
1995
- 1995-11-28 IL IL11616895A patent/IL116168A0/xx unknown
- 1995-11-30 ZA ZA9510184A patent/ZA9510184B/xx unknown
- 1995-12-04 TR TR95/01530A patent/TR199501530A1/xx unknown
- 1995-12-04 MA MA24086A patent/MA23737A1/fr unknown
- 1995-12-05 JP JP8517359A patent/JPH10509729A/ja not_active Ceased
- 1995-12-05 SK SK685-97A patent/SK68597A3/sk unknown
- 1995-12-05 PL PL95320564A patent/PL320564A1/xx unknown
- 1995-12-05 KR KR1019970703784A patent/KR980700083A/ko not_active Withdrawn
- 1995-12-05 AU AU43073/96A patent/AU4307396A/en not_active Abandoned
- 1995-12-05 CA CA002207028A patent/CA2207028A1/en not_active Abandoned
- 1995-12-05 CZ CZ971753A patent/CZ175397A3/cs unknown
- 1995-12-05 EP EP95941761A patent/EP0797444A1/fr not_active Withdrawn
- 1995-12-05 CN CN95196670A patent/CN1168634A/zh active Pending
- 1995-12-05 HU HU9702097A patent/HUT77382A/hu unknown
- 1995-12-05 BR BR9509961A patent/BR9509961A/pt not_active Application Discontinuation
- 1995-12-05 FI FI972383A patent/FI972383A0/fi not_active Application Discontinuation
- 1995-12-05 AR ARP950100438A patent/AR002946A1/es unknown
- 1995-12-05 WO PCT/FR1995/001596 patent/WO1996017616A1/fr not_active Application Discontinuation
-
1997
- 1997-06-05 NO NO972558A patent/NO972558L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL116168A0 (en) | 1996-01-31 |
| FI972383L (fi) | 1997-06-05 |
| CN1168634A (zh) | 1997-12-24 |
| FR2727629A1 (fr) | 1996-06-07 |
| AU4307396A (en) | 1996-06-26 |
| FI972383A7 (fi) | 1997-06-05 |
| KR980700083A (ko) | 1998-03-30 |
| TR199501530A1 (tr) | 1996-10-21 |
| CZ175397A3 (en) | 1997-10-15 |
| ZA9510184B (en) | 1996-06-11 |
| FI972383A0 (fi) | 1997-06-05 |
| BR9509961A (pt) | 1997-11-25 |
| MA23737A1 (fr) | 1996-07-01 |
| WO1996017616A1 (fr) | 1996-06-13 |
| HUT77382A (hu) | 1998-04-28 |
| JPH10509729A (ja) | 1998-09-22 |
| FR2727629B1 (enrdf_load_stackoverflow) | 1997-02-28 |
| EP0797444A1 (fr) | 1997-10-01 |
| CA2207028A1 (en) | 1996-06-13 |
| AR002946A1 (es) | 1998-05-27 |
| PL320564A1 (en) | 1997-10-13 |
| NO972558D0 (no) | 1997-06-05 |
| MX9704105A (es) | 1997-09-30 |
| SK68597A3 (en) | 1997-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122006000010I2 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten | |
| ES2150979T3 (es) | Formulado de acidos bisfosfonicos a partir de una mezcla seca. | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| DE3463442D1 (en) | Arched bridge staple | |
| NO20092860L (no) | 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
| NO307408B1 (no) | Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev | |
| EP0209689A3 (en) | Use of tetrahydrobiopterins in the treatment of infantile autism | |
| DK0480934T3 (da) | Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt | |
| IS3703A7 (is) | Aðferð til framleiðslu á efnasamsetningu til lækninga, sem er samverkandi og starfsmagnandi og aðferðir við notkun hennar | |
| DE69738000D1 (de) | Neue Arzneiformulierung enthaltend Budesonide | |
| EP0705100A4 (en) | THERAPEUTIC SUBSTITUTED GUANIDINES | |
| DK549189D0 (da) | Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge | |
| NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
| ATE203907T1 (de) | Dermatologische zubereitung zur behandlung von aktinischen keratosen | |
| DE69316013D1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
| ATE131060T1 (de) | Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane. | |
| NO155375C (no) | Naturlig vev egnet for implantering i en levende kropp samt fremgangsmaate til aa redusere forkalkningen av naturlig vev som finner sted etter implanteringen i en levende kropp | |
| NO894222D0 (no) | Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder. | |
| NO972558L (no) | Sett for osteoporose-behandlingssyklus | |
| IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
| NZ326345A (en) | Composition containing diosgenin | |
| ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
| AU3108289A (en) | Compositions comprising 24,25-dihydroxy-vitamin D3 and calcium for the treatment of osteoporosis in humans | |
| ATE149840T1 (de) | Behandlung von leberkrebs |